TRIVACTON 6 injekčná suspenzia pre hovädzí dobytok
TRIVACTON 6 injekčná suspenzia pre hovädzí dobytok
Authorised
- Bovine coronavirus, strain CR1, Inactivated
- Bovine rotavirus A, strain RoI, Inactivated
- Escherichia coli, serotype O101 (fimbrial adhesin F41), Inactivated
- Escherichia coli, serotype O78 (antigen 31A), Inactivated
- Escherichia coli, serotype O117 (antigen Y), Inactivated
- Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
Product identification
Medicine name:
TRIVACTON 6 injekčná suspenzia pre hovädzí dobytok
Active substance:
- Bovine coronavirus, strain CR1, Inactivated
- Bovine rotavirus A, strain RoI, Inactivated
- Escherichia coli, serotype O101 (fimbrial adhesin F41), Inactivated
- Escherichia coli, serotype O78 (antigen 31A), Inactivated
- Escherichia coli, serotype O117 (antigen Y), Inactivated
- Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
Target species:
-
Cattle (pregnant cow)
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Bovine coronavirus, strain CR1, Inactivated1.50/serum neutralising unit(s)5.00millilitre(s)
-
Bovine rotavirus A, strain RoI, Inactivated2.00/haemagglutination inhibiting unit(s)5.00millilitre(s)
-
Escherichia coli, serotype O101 (fimbrial adhesin F41), Inactivated0.90/antibody unit(s)5.00millilitre(s)
-
Escherichia coli, serotype O78 (antigen 31A), Inactivated0.90/antibody unit(s)5.00millilitre(s)
-
Escherichia coli, serotype O117 (antigen Y), Inactivated0.90/antibody unit(s)5.00millilitre(s)
-
Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated0.90/antibody unit(s)5.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle (pregnant cow)
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AL
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovakia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
- 97/156/00-S
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Slovak (PDF)
Published on: 26/01/2022